NASDAQ Gain Momentum on News (IPXL, HIMX, CREE, ACUR, ZOLT)

New York, NY -- (SBWIRE) -- 03/05/2013 -- Impax Laboratories Inc (NASDAQ:IPXL) Impax Laboratories Inc is selling off due to the FDA has issuing a new Form 483 with twelve observations following re-inspection of company's Hayward manufacturing facility. Trading at an intraday of $15.70 (-21.5%) with over 250,000 shares that have exchanged hands, will IPXL stay above its new current 52 week low of $15.60? Stay tuned.

Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) Himax Technologies Inc. is following recent bullish momentum, trading at an intraday of $4.17 (+21.22%) with over 380,000 shares exchanged, will HIMX break its new 52 week high of $4.30? Stick around.

Cree, Inc. (NASDAQ:CREE) introduces a game-changing series of LED bulbs at a retail price point that gives consumers a reason to switch to LED lighting. Trading at an intraday of $47.40 (+5.99%) with over 318,000 shares traded, will CREE break its new 52 week high of $48.95? Stick around.

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) today announced that its new next generation pseudoephedrine with abuse deterrent technology will now be stocked by chain drug store KERR DRUG. Nexafed®. Trading at an intraday of $3,20 (+56.1%) with over 2.1 million shares that have exchanged hands, will ACUR continue to push towards the end of day? Stick around.

Zoltek Companies, Inc. (NASDAQ:ZOLT) Quinpario Partners LLC announced yesterday the formation of a group consisting of highly competent and reputable investors and director candidates with respect to Quinpario's investment in Zoltek Companies, Inc. Trading at an intraday of $11.251 (+21.63%) with over 870,000 shares exchanged, will ZOLT continue to push north? Stick around.

View Full NASDAQ Report: http://toonicestocks.com/news/2918-nasdaq-gain-momentum-news-ipxl-himx-cree-acur-zolt

About TooNiceStocks.com
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.

None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.